Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections

Transplanting hepatitis C viremic donor organs into hepatitis C virus (HCV)-negative recipients is becoming increasingly common; however, practices for posttransplant direct-acting antiviral (DAA) treatment vary widely. Protracted insurance authorization processes for DAA therapy often lead to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Zoe A., Stern, Jeffrey, Ali, Nicole M., Kalia, Harmit S., Khalil, Karen, Jonchhe, Srijana, Weldon, Elaina P., Dieter, Rebecca A., Lewis, Tyler C., Funches, Nur, Crosby, Sudara, Seow, Monique, Berger, Jonathan C., Dagher, Nabil N., Gelb, Bruce E., Watkins, Anthony C., Moazami, Nader, Smith, Deane E., Kon, Zachary N., Chang, Stephanie H., Reyentovich, Alex, Angel, Luis F., Montgomery, Robert A., Lonze, Bonnie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425828/
https://www.ncbi.nlm.nih.gov/pubmed/34514117
http://dx.doi.org/10.1097/TXD.0000000000001222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425828/
https://www.ncbi.nlm.nih.gov/pubmed/34514117
http://dx.doi.org/10.1097/TXD.0000000000001222

Ejemplares similares